Cargando…
Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via ATM‑ERK cascade in adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare but malignant tumor. Surgical removal, radiotherapy and combined chemotherapy are commonly used to treat ACC. Despite efforts for several decades, the mortality rate of ACC remains high after treatments. Therefore, identifying a novel therapeutic molecule is...
Autores principales: | Lin, Ruei-Ci, Chao, Yu-Ying, Lien, Wei-Chih, Chang, Huei-Cih, Tsai, Shih-Wei, Wang, Chia-Yih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394735/ https://www.ncbi.nlm.nih.gov/pubmed/37477142 http://dx.doi.org/10.3892/or.2023.8604 |
Ejemplares similares
-
Etoposide Triggers Cellular Senescence by Inducing Multiple Centrosomes and Primary Cilia in Adrenocortical Tumor Cells
por: Teng, Yen-Ni, et al.
Publicado: (2021) -
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018) -
BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells
por: Lian, Guodong, et al.
Publicado: (2018) -
BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells
por: Cheng, Chieh-Yuan, et al.
Publicado: (2018) -
BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer
por: Huo, Jianting, et al.
Publicado: (2022)